TEVA PHARMACEUTICAL-SP ADR (TEVA) Institutional Ownership Changes & 13F Activity

TEVA PHARMACEUTICAL-SP ADR (TEVA). Institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC Form 13F filings. This page analyzes institutional buying and selling activity, new holdings, and sold-out positions among tracked filers. Notable filers include Sound Shore Management, Greenlight Capital, ARK Invest, Sequoia Financial Advisors, and Viking Global Investors.

Portfolio quarterNameTypeQuantityRemainingReported stock balance
Q4 2018Renaissance Technologies LLCBuy3,472,3226,941,985$107,045
Q4 2018Abrams Capital ManagementSell-1,000,00018,522,372$285,615
Q4 2018Miller Value PartnersBuy6,3503,911,802$60,320
Q4 2018ARK InvestBuy54323,606$364
Q3 2018Renaissance Technologies LLCBuy2,568,7003,469,663$74,737
Q3 2018Miller Value PartnersBuy1,316,8403,905,452$84,123
Q3 2018Abrams Capital ManagementSell-220,75119,522,372$420,512
Q3 2018ARK InvestSell-7,42423,063$497
Q2 2018Berkshire HathawayBuy2,709,58543,249,295$1,051,823
Q2 2018Miller Value PartnersBuy393,6402,588,612$62,955
Q2 2018ARK InvestBuy2,56130,487$741
Q1 2018Berkshire HathawayBuy21,663,98940,539,710$692,824
Q1 2018Renaissance Technologies LLCSell-3,916,800900,963$15,397
Q1 2018Miller Value PartnersBuy1,678,8602,194,972$37,512
Q1 2018ARK InvestBuy10,76227,926$477
Q4 2017Berkshire HathawayBuy18,875,72118,875,721$357,695
Q4 2017Abrams Capital ManagementSell-1,880,76319,743,123$374,132
Q4 2017Miller Value PartnersBuy516,112516,112$9,780
Q4 2017Chou Associates ManagementSell-490,00015,000$284
Q4 2017ARK InvestBuy17,16417,164$325
Q3 2017Abrams Capital ManagementBuy19,062,61721,623,886$380,580
Q3 2017Muhlenkamp & CoSell-105,805700$12
Q2 2017Chou Associates ManagementBuy290,000505,000$16,839
Q2 2017Muhlenkamp & CoBuy1,378106,505$3,538
Q1 2017Appaloosa ManagementSell-2,878,0002,175,000$69,796
Q1 2017Renaissance Technologies LLCBuy2,651,9004,817,763$154,602
Q1 2017Chou Associates ManagementBuy215,000215,000$6,899
Q1 2017Muhlenkamp & CoSell-134,762105,127$3,374
Q4 2016Appaloosa ManagementBuy5,053,0005,053,000$183,171
Q4 2016Renaissance Technologies LLCBuy217,9002,165,863$78,513

Frequently asked questions about TEVA activity

  • Which institutional owners are buying TEVA?

    Institutional owners buying TEVA include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.

  • What does "buy" mean in TEVA activity?

    "Buy" means an investor increased their reported position in TEVA compared to the prior reporting period. This reflects growing exposure to TEVA PHARMACEUTICAL-SP ADR (TEVA) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).

  • Is institutional interest in TEVA increasing?

    Institutional interest in TEVA can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.

Related TEVA Institutional Insights